CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Research and development (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $397M | +2.7% | 33.8% | 24.5% |
| Research and development (TTM) | $397M |
|---|---|
| YoY | +2.7% |
| 5-year CAGR | 33.8% |
| 10-year CAGR | 24.5% |
Research and development
| Period | R&D | YoY |
|---|---|---|
| 2025 | $416M | +22.6% |
| 2024 | $339M | +2.8% |
| 2023 | $330M | +37.1% |
| 2022 | $241M | +50.6% |
| 2021 | $160M | +65.0% |
| 2020 | $97M | +12.6% |
| 2019 | $86M | −3.4% |
| 2018 | $89M | −1.3% |
| 2017 | $90M | +50.8% |
| 2016 | $60M | +29.1% |
| 2015 | $46M | +4.4% |
| 2014 | $44M | −10.2% |
| 2013 | $49M | +38.7% |
| 2012 | $36M | −4.1% |
| 2011 | $37M | −2.2% |
| 2010 | $38M | −4.6% |
| 2009 | $40M | — |